The Impact of Secondary Prevention Programs Incorporating Remote Technologies on Psychological Well-Being and Quality of Life in Coronary Heart Disease Patients with Abdominal Obesity

Background: Quality of life, which is determined both by the physical symptoms and by psychosocial risk factors, is among the primary treatment goals in coronary heart disease (CHD). Therefore, it is reasonable to assess the impact of any therapeutic interventions in CHD on these measures. Aim: To assess the changes of psychological status and quality of life in patients with CHD and abdominal obesity (AO) over time during 2 secondary prevention programs using two different modalities of remote support. Methods: An open-label randomized study with 3 parallel groups enrolling hospitalized patients with stable CHD and AO (most hospitalizations were due to elective revascularization procedures). The patients were randomized into 2 intervention groups (Group I and Group II) and into Group III (control). Both intervention groups received secondary prevention programs including one in-hospital preventive counselling session with focus on healthy eating habits and subsequent remote support for 6 months (Month 1 to 3: once a week; Month 4 to 6: once a month). Group I received this subsequent counselling via phone calls and Group II received text messages via different platforms according to patient preferences. Group III received standard advice at discharge only. During 1 year of follow-up motivation for lifestyle changes and continued participation in secondary prevention programs, anxiety and depression symptoms (HADS), stress levels (10-point VAS) and quality of life (HeartQol) were assessed. Results: A total of 120 patients were enrolled (mean age±SD, 57.75±6.25 years; men, 83.4%) who had a high baseline motivation to participate in preventive programs. At 1 year of follow-up there was a substantial improvement in anxiety and depression symptoms in Groups I and II which was absent in Group III. As a result, the proportion of patients with HADS-A score ≥8 dropped from 45.0% to 10.0% in Group I and from 40.0% to 7.5% in Group II (both р values <0.01 vs control), and the proportion of participants with HADS-D ≥8 decreased from 30.0% to 10.0% (р<0.01 vs control) and from  12.5% to 0% (р<0.05 vs control), respectively. Stress level decreased in Groups I and II by 3.95±0.38 and 3.56±0.39 баллов, respectively (both р values <0.01 vs control). The HeartQol global score increased by 1.07±0.08 points in Group I and by 0.98±0.13 points in Group (both р values <0.01 vs control). Conclusion: Both secondary prevention programs with long-term remote support targeting obese CHD patients resulted in improvement of pivotal measures of their psychological status i.e. into a decline of anxiety and depression symptomatology, stress reduction and into a better quality of life.

1. Boytsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23(6):7–122. DOI: 10.15829/1560-4071-2018-6-7-122

2. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2016;37(29):2315–81. DOI: 10.1093/eurheartj/ehw106

3. Pogosova N, Kotseva K, De Bacquer D, von Känel R, De Smedt D, Bruthans J et al. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. European Journal of Preventive Cardiology. 2017;24(13):1371–80. DOI: 10.1177/2047487317711334

4. Pogosova N.V., Boytsov S.A., Oganov R.G., Kostyuk G.P., Sokolova O.Yu., Yufereva Yu.M. et al. Psychosocial Risk Factors in Ambulatory Patients With Arterial Hypertension and Ischemic Heart Disease of 30 Cities in Russia: Data from the КОМЕТА (Сomet) Study. Kardiologiia. 2018;58(11):5–16. DOI: 10.18087/cardio.2018.11.10193

5. Oganov R.G., Pogosova G.V., Koltunov I.E., Romasenko L.V., Deev A.D., Yufereva Yu.M. Depressive Symptoms Worsen Cardiovascular Prognosis and Shortens Length of Life in Patients With Arterial Hypertension and Ischemic Heart Disease. Kardiologiia. 2011;51(2):59–66.

6. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014;129(12):1350–69. DOI: 10.1161/CIR.0000000000000019

7. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry. 2011;33(3):203–16. DOI: 10.1016/j.genhosppsych.2011.02.007

8. Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. American Heart Journal. 2015;170(6):1105–15. DOI: 10.1016/j.ahj.2015.09.013

9. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH et al. Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies. Archives of General Psychiatry. 2010;67(3):220–9. DOI: 10.1001/archgenpsychiatry.2010.2

10. Tyrrell J, Mulugeta A, Wood AR, Zhou A, Beaumont RN, Tuke MA et al. Using genetics to understand the causal influence of higher BMI on depression. International Journal of Epidemiology. 2019;48(3):834–48. DOI: 10.1093/ije/dyy223

11. Pogosova N.V., Salbieva A.O., Sokolova O.Yu., Ausheva A.K., Karpova A.V., Eganyan R.A. et al. The Efficacy of Secondary Prevention Programs with Remote Support in Ischemic Heart Disease Patients with Abdominal Obesity. Kardiologiia. 2019;59(11):21–30. DOI: 10.18087/cardio.2019.11.n739

12. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise. 2003;35(8):1381–95. DOI: 10.1249/01.MSS.0000078924.61453.FB

13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361–70. PMID: 6880820

14. Pogosova N.V., Baycharov I.H., Sokolova O.Yu., Vygodin V.A. The New European Questionnaire for Assessment of Quality of Life of Patients With Ischemic Heart Disease: HeartQoL. Kardiologiia. 2016;56(8):66–72. DOI: 10.18565/cardio.2016.8.66-72

15. Anderson L, Brown JP, Clark AM, Dalal H, Rossau HK, Bridges C et al. Patient education in the management of coronary heart disease. The Cochrane Database of Systematic Reviews. 2017;6:CD008895. DOI: 10.1002/14651858.CD008895.pub3

16. Commodore-Mensah Y, Dennison Himmelfarb CR. Patient Education Strategies for Hospitalized Cardiovascular Patients: A Systematic Review. The Journal of Cardiovascular Nursing. 2012;27(2):154–74. DOI: 10.1097/JCN.0b013e318239f60f

17. Esmaeili Vardanjani SA, Fanisaberi L, Alirezaee Shahraki F, Khalilzadeh A, Tavakoli Vardanjani A, Ghani Dehkordi F. The Effect of Face-to-Face Education and Educational Booklet on Heart Health Indexes of the Hospitalized Patients with Myocardial Infarction. Nursing Research and Practice. 2013;2013:675634. DOI: 10.1155/2013/675634

18. Hoseini S, Soltani F, Babaee Beygi M, Zarifsanaee N. The effect of educational audiotape programme on anxiety and depression in patients undergoing coronary artery bypass graft. Journal of Clinical Nursing. 2013;22(11–12):1613–9. DOI: 10.1111/jocn.12125

19. Tsai S-T, Chou F-H. The effectiveness of multimedia nursing education on reducing illness-related anxiety and uncertainty in myocardial infarction patients after percutaneous coronary intervention. Hu Li Za Zhi The Journal of Nursing. 2012;59(4):43–53. DOI: 10.6224/JN.59.3.43

20. O’Neil A, Hawkes AL, Atherton JJ, Patrao TA, Sanderson K, Wolfe R et al. Telephone-delivered health coaching improves anxiety outcomes after myocardial infarction: the ‘ProActive Heart’ trial. European Journal of Preventive Cardiology. 2014;21(1):30–8. DOI: 10.1177/2047487312460515

21. Saki A, Bahabadi AH, Noghabi AA, Mehran A. Comparison of faceto-face and electronic education methods on anxiety in patients with acute myocardial infarction. Hayat. 2014;20(1):6–14. [Av at: http://hayat.tums.ac.ir/article-1-684-en.html]

22. Chipidza FE, Wallwork RS, Stern TA. Impact of the Doctor-Patient Relationship. The Primary Care Companion For CNS Disorders. 2015;17(5). DOI: 10.4088/PCC.15f01840

23. Kesänen J, Leino-Kilpi H, Lund T, Montin L, Puukka P, Valkeapää K. Increased preoperative knowledge reduces surgery-related anxiety: a randomised clinical trial in 100 spinal stenosis patients. European Spine Journal. 2017;26(10):2520–8. DOI: 10.1007/s00586-017-4963-4

24. Wells A. Metacognitive Therapy for anxiety and depression in cardiac rehabilitation: Commentary on the UK National Institute of Health Research funded PATHWAY programme. Journal of Cardiology and Cardiovascular Sciences. 2018;2(3):10–4. DOI: 10.29245/2578-3025/2018/3.1131